Winton Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-41,630
Closed -$838K – 972
2025
Q3
$838K Buy
+41,630
New +$697K 0.03% 490
2025
Q1
– Sell
-11,666
Closed -$141K – 701
2024
Q4
$141K Buy
+11,666
New +$153K 0.01% 577
2024
Q3
– Sell
-18,479
Closed -$267K – 664
2024
Q2
$267K Buy
+18,479
New +$295K 0.02% 504
2021
Q2
– Sell
-14,066
Closed -$414K – 1441
2021
Q1
$414K Buy
14,066
+3,313
+31% +$102K 0.02% 978
2020
Q4
$330K Buy
+10,753
New +$328K 0.02% 995
2020
Q3
– Sell
-153,630
Closed -$3.29M – 1508
2020
Q2
$3.29M Sell
153,630
-47,912
-24% -$1.06M 0.09% 412
2020
Q1
$4.51M Sell
201,542
-80,257
-28% -$2.2M 0.12% 287
2019
Q4
$8.3M Buy
+281,799
New +$7.66M 0.12% 301

Other funds holding ELAN

Winton Group's ELAN Position: Q4 2025 in Review

Winton Group sold out of Elanco Animal Health (ELAN) in Q4 2025, closing a stake of 41,630 shares — an estimated $838K sold.

Winton Group first reported a position in ELAN in Q4 2019 and held it in 8 quarters. The position peaked at $8.3M in Q4 2019. 486 funds tracked by Wall St. Rank hold ELAN as of Q4 2025.

  • Winton Group reported no remaining Elanco Animal Health position as of Q4 2025 after selling out during the quarter.
  • Winton Group sold 41,630 Elanco Animal Health shares in Q4 2025, an estimated $838K.
  • Winton Group first reported a position in Elanco Animal Health in Q4 2019 and held it in 8 quarters.
  • Winton Group's Elanco Animal Health position peaked at $8.3M in Q4 2019.
  • 486 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2025.

Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.